Clinical trial
Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual…
NCT02829151 · Yonsei University, Other · Unknown status
Key facts
| NCT number | NCT02829151 |
|---|---|
| Title | Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study) |
| Official title | Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study) |
| Lead sponsor | Yonsei University, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Critical Limb Ischemia |
| Intervention type | Drug |
| Interventions | Triple antiplatelet therapy (aspirin (100 mg), clopidogrel (75 mg), and cilostazol (200 mg) ), Dual antiplatelet therapy (aspirin (100 mg) and clopidogrel (75 mg)) using aspirin and clopidogrel, Dual antiplatelet therapy (aspirin (100 mg) and cilostazol (200 mg)) using aspirin and cilostazol |
| Enrollment | 390 |
| Start date | Feb 21, 2017 |
| Primary completion | Oct 1, 2021 |
| Completion | Oct 1, 2021 |
| First posted | Jul 12, 2016 |
| Last update posted | Jan 14, 2019 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: